Jones anchored her discussion in a core philosophy for veterinary oncology: "one size does not fit all.” According to Jones, ...
Combination Potential: When combined with an anti-PD-1 antibody, Compound 10 significantly inhibited tumor growth, ...
Opna Bio, a clinical-stage biopharmaceutical company focused on the discovery and development of novel oncology therapeutics, announced promising preclinical data from the company's novel, ...
A new clinical trial suggests that pairing bispecific antibodies and antibody-drug conjugates with CAR T-cell therapy may ...
A study published in the Journal of Clinical Oncology confirms that one of the first Food and Drug Administration-approved CAR-T cell therapies offers long-term survival and potential cures for adult ...
News-Medical.Net on MSN
Combination therapy may boost survival for people with aggressive lymphoma
A new clinical trial suggests that pairing bispecific antibodies and antibody-drug conjugates with CAR T-cell therapy may ...
News-Medical.Net on MSN
Lymphocyte levels help predict outcomes after CAR T-cell therapy in non-Hodgkin lymphoma
Measuring the lymphocytes - white blood cells that fight infection - in a patient's blood can be used to predict outcomes in ...
In a head-to-head trial, Lilly’s drug was as effective as Imbruvica at inducing responses and displayed certain safety ...
In Northwest Alaska, a proposed 211-mile mining road has divided an Inupiaq community already devastated by climate change.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback